Authors:
Maahs DM, Buckingham BA, Castle JR, Cinar A, Damiano ER, Dassau E, ... Jones TW, et al.
Authors notes:
A consensus report. Diabetes Care. 2016;39(7):1175-9.
Keywords:
Artificial pancreas, glucose monitoring, clinical trials, outcome measures, JDRF Artificial Pancreas Project Consortium
Abstract:
Research on and commercial development of the artificial pancreas (AP) continue to progress rapidly, and the AP promises to become a part of clinical care.
In this report, members of the JDRF Artificial Pancreas Project Consortium in collaboration with thewider AP community
1) advocate for the use of continuous glucose monitoring glucosemetrics as outcomemeasures in AP trials, in addition to HbA1c, and
2) identify a short set of basic, easily interpreted outcome measures to be reported in AP studies whenever feasible.
Consensus on a broader range of measures remains challenging; therefore, reporting of additional metrics is encouraged as appropriate for individual AP studies or study groups.
Greater consistency in reporting of basic outcome measures may facilitate the interpretation of study results by investigators, regulatory bodies, health care providers, payers, and patients themselves, thereby accelerating the widespread adoption of AP technology to improve the lives of people with type 1 diabetes.